Ichthyosis
MONDO:0019269Disorders of cornification that are characterized by visible scaling and/or hyperkeratosis of most or all of the skin. Inherited ichthyoses, defined as the generalized form of Mendelian disorders of cornification, affect most or all of the skin. This etiologically and phenotypically heterogenous group of conditions is caused by mutations in various different genes important for keratinocyte differentiation and epidermal barrier function. Acquired forms of ichthyosis can be observed with certain autoimmune, inflammatory, metabolic, endocrine, or infectious diseases or with malignancies.
Also known as: DOC, disorder of cornification, fish scale disease, fish skin disease, ichthyosis, ichthyosis (disease), non-syndromic ichthyosis
40 clinical trials for this condition and its sub-types, 13 tagged with Ichthyosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Ichthyosis
-
Inherited ichthyosis 6 trials · 32 incl. sub-types
13 sub-types
- Netherton syndrome 15 trials
- Autosomal recessive congenital ichthyosis 2 trials · 10 incl. sub-types Sub-types →
- Keratinopathic ichthyosis 0 trials · 7 incl. sub-types Sub-types →
- Ichthyosis vulgaris 3 trials Sub-types →
- Recessive X-linked ichthyosis 2 trials Sub-types →
- Peeling skin syndrome 1 trial Sub-types →
- IFAP syndrome 0 trials Sub-types →
- Congenital cataract-ichthyosis syndrome 0 trials
- Ichthyosis hystrix 0 trials Sub-types →
- Ichthyosis linearis circumflexa 0 trials
- Ichthyosis with erythrokeratoderma 0 trials
- Ichthyosis-oral and digital anomalies syndrome 0 trials
- Neonatal ichthyosis-sclerosing cholangitis syndrome 0 trials
-
Acquired ichthyosis 0 trials
-
Ichthyosis, follicular 0 trials
Most studied deeper sub-types
-
Experimental drug for rare skin disease fails to reach goal
Disease control Stopped earlyThis early-stage trial tested a drug called DS-2325a in 9 adults with Netherton syndrome, a rare genetic condition causing severe skin redness, scaling, and allergies. The study aimed to check safety and whether the drug could help control the disease. However, the trial was term…
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Hope for rare skin disease: new drug shows promise in trial
Disease control Stopped earlyThis study tested a medicine called spesolimab for people with Netherton syndrome, a rare genetic skin condition causing severe redness and scaling. About 43 people aged 12 and older took part, receiving either the drug or a placebo. The goal was to see if spesolimab could reduce…
Phase 2/3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Promising ichthyosis drug trial stalls after just 5 patients
Disease control Stopped earlyThis study tested a drug called imsidolimab (ANB019) in people with ichthyosis, a condition that causes dry, scaly, and red skin. The trial aimed to see if the drug could improve skin symptoms compared to a placebo. However, the study was stopped early and only enrolled 5 partici…
Phase 2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
Rare skin disease study seeks to understand netherton syndrome
Knowledge-focused Stopped earlyThis study aimed to collect real-world data on Netherton Syndrome, a rare genetic skin disorder. Researchers planned to follow 4 participants over 52 weeks, measuring skin severity and other symptoms. The study was terminated early, so results are limited.
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC